Dallas, TX 8/5/2009 11:02:09 PM
ALRX, NVSR, UNDT, CMLS, ONT, DARA, August 5 Daily Market Movers Digest Report from OTCPicks.com
OTCPicks.com’s Daily Small Cap and Microcap Newsletter presents a range of the hottest small cap stocks on trading on the OTC and OTCBB markets. In addition to our Newsletters, OTCPicks.com is quickly becoming the premier community destination for small cap and microcap traders to meet up and discuss their top stock picks. Visit http://www.otcpicks.com/microcap.htm today to join this growing community. Our Stocks to Watch today include AlphaRx Inc. (OTCBB: ALRX), NavStar Technologies Inc. (OTC: NVSR), Universal Detection Technology (OTCBB: UNDT), Cumulus Media Inc. (Nasdaq: CMLS), On2 Technologies Inc. (Amex: ONT) and DARA BioSciences Inc. (Nasdaq: DARA). For the complete newsletter please visit: http://www.otcpicks.com/daily-market-movers/index.php For more in-depth coverage of small cap stocks visit http://www.otcpicks.com/microcap.htm ALPHARX INCORPORATED (OTCBB: ALRX) "Up 3.16% in morning trading" Company Profile: http://www.otcpicks.com/alpharx/alpharx.htm AlphaRx is a specialty pharmaceutical company dedicated to developing proven therapies by reformulating FDA approved and marketed drugs which through the application of its proprietary site-specific nano drug delivery technology, offers improved medical benefits and a potential for significant commercial product development. NAVSTAR TECHNOLOGIES INCORPORATED (OTC: NVSR) Company Profile: http://www.otcpicks.com/navstar-technologies/navstar-technologies.htm NavStar is focused on the creation of GPS products and services that provide wireless tracking of vehicles, equipment, and other valuable and personal assets. The goal is to be a total solutions provider. UNIVERSAL DETECTION TECHNOLOGY (OTCBB: UNDT) "Up 38.64% in morning trading" Universal Detection Technology is a developer of monitoring technologies, including bioterrorism detection devices. The company on its own and with development partners is positioned to capitalize on opportunities related to Homeland Security. For example, the company, in cooperation with NASA, has developed a bacterial spore detector that detects certain biohazard substances. The company is also a reseller of handheld assays used for detection of five bioterrorism agents, radiation detection systems, and antimicrobial products. CUMULUS MEDIA INCORPORATED (NASDAQ: CMLS) "Up 53.44% in morning trading" Cumulus Media, Inc. engages in the acquisition, operation, and development of frequency modulation and amplitude modulation radio stations in mid-size radio markets in the United States. The company, through its investment in Cumulus Media Partners, LLC, also operates radio station clusters for large-sized markets. It also provides sales and marketing services for one radio station under a local marketing agreement. As of December 31, 2007, Cumulus Media owned and operated 303 stations in 56 mid-sized U.S. markets and operated 33 radio stations in 8 markets, including San Francisco, Dallas, Houston, and Atlanta that were owned by CMP under a local marketing agreement. The company was founded in 1997 and is based in Atlanta, Georgia. ON2 TECHNOLOGIES INCORPORATED (AMEX: ONT) "Up 51.27% in morning trading" On2 creates advanced video compression technologies that power the video in today’s leading desktop and mobile applications and devices. On2 customers include Adobe, Skype, Nokia, Infineon, Sun Microsystems, Mediatek, Sony, Brightcove, and Move Networks. On2 Technologies is headquartered in Clifton Park, NY USA. DARA BIOSCIENCES INCORPORATED (NASDAQ: DARA) "Up 49.97% in morning trading" DARA BioSciences™ Inc. ("DARA") is a Raleigh, North Carolina based development-stage pharmaceutical company that acquires promising therapeutic small molecules and develops them through proof of concept in humans for subsequent sale or out-licensing to larger pharmaceutical companies. Presently DARA has two drug candidates with cleared IND's (Investigational New Drug) Applications from the US FDA. One of these drug candidates KRN5500 has successfully completed a Phase 2a clinical trial treating cancer patients for neuropathic pain. It has a portfolio of drug candidates for neuropathic pain, type 2 diabetes, and psoriasis. About OTCPicks.com OTCPicks.com is fast becoming the premier Internet destination for investors seeking information on smallcap and microcap companies. The web site features companies in Profile Campaigns, Executive Interviews and Research Reports authored by our financial writers. We publish our Daily Market Movers Digest Newsletter to opt-in investor members. OTCPicks.com presents the latest information for the discerning small cap and microcap investor. The site features informative articles on microcap investing, the top penny stock picks, and a wealth of small cap research on vertical markets. To feature a company on OTCPicks.com, please contact our publisher, Brian Dean at 972-546-3740, or via email at publisher@otcpicks.com. Forward-Looking Statement: This press release includes "forward-looking statements" within the meaning of the federal securities laws, commonly identified by such terms as "believes," "looking ahead," "anticipates," "estimates" and other terms with similar meaning. Although the Company believes that the assumptions upon which its forward-looking statements are based are reasonable, it can give no assurance that these assumptions will prove to be correct. Important factors that could cause actual results to differ materially from the Company's projections and expectations are disclosed in the Company's filings with the Securities and Exchange Commission. All forward-looking statements in this press release are expressly qualified by such cautionary statements and by reference to the underlying assumptions. Disclosure: OTCPicks.com has been compensated seven thousand five hundred dollars by a third party (Blue Wave Advisors) for ALRX advertising and promotional services. OTCPicks.com has been compensated eight thousand dollars by a third party (Mickey Reno) for NVSR advertising and promotional services. OTCPicks.com is not a registered investment advisers or broker/dealer. OTCPicks.com makes no recommendation that the purchase of securities of companies profiled in this website is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market their securities, investing in such securities is highly speculative and carries a high degree of risk.
